All In Biotech

Drug Trial Radar · NCT06092762

A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis

a Multicenter, Randomized, Open Label Phase II Clinical Study to Evaluate the Safety and Efficacy of AK120 in the Treatment of Subjects With Moderate to Severe Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Nov 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

180

Actual

Start

Nov 6, 2023

Primary completion

Nov 13, 2024

Study completion Nov 13, 2024

Sponsor

Lead sponsor
AkesoIndustry
Sponsor type
Industry
First posted
Oct 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, open label phase II clinical study to evaluate the safety and efficacy of AK120 in the treatment of subjects with moderate to severe atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • AK120Drug

    subcutaneous injection every 2 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events(AE)Time frame: week 0 to week 24

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • Air Force Medical Center

    Beijing, Beijing Municipality, China

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, China

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China

  • The Second Affiliated Hospital of Xiamen Medical College

    Xiamen, Fujian, China

  • Dongguan People's Hospital

    Dongguan, Guangdong, China

  • Dermatology Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, China

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • People Hospital of Xingtai

    Xingtai, Hebei, China

  • Renmin Hospital of Wuhan University Hubei General Hospital

    Wuhan, Hubei, China

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, China

  • Yancheng No.1 People's Hospital

    Yancheng, Jiangsu, China

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, China

  • Qingdao Municipal Hospital

    Qingdao, Shandong, China

  • Baoji Central Hospital

    Baoji, Shanxi, China

  • Second Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

  • Taiyuan Central Hospital

    Taiyuan, Shanxi, China

  • Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital

    Tianjin, Tianjin Municipality, China

  • The First Affiliated Hospital,Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • Ningbo No.2 Hospital

    Ningbo, Zhejiang, China

  • The first affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine

    Yiwu, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.